Patient-reported frequency of taking aspirin in a population with coronary artery disease

American Journal of Cardiology

Volumn 89, Issue 9, 2002, Pages 1042-1046

  Allen LaPointe, Nancy M ^a   Kramer, Judith M ^a   DeLong, Elizabeth R ^a   Ostbye, Truls ^a   Hammill, Bradley G ^a   Muhlbaier, Lawrence H ^a   McCants, Charles B ^a   Chen, Anita ^a   Califf, Robert M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG USE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; DRUG HYPERSENSITIVITY; HEALTH CARE SURVEYS; HUMANS; NORTH CAROLINA; PLATELET AGGREGATION INHIBITORS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; SELF ADMINISTRATION; SELF MEDICATION;

EID: 0036570039     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02272-5     Document Type: Article

References (13)

1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
2. Aspirin and secondary mortality after myocardial infarction
3. The German-Austrian aspirin trial: A comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction
4. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction
5. Collaborative overview of randomized trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
6. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
7. Aspirin use is low among United States outpatients with coronary artery disease
8. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease
9. Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: Missed opportunities for prevention?
10. Underuse of acetylsalicylic acid in individuals with myocardial infarction, ischemic heart disease or stroke: Data from the 1995 population-based Nova Scotia Health Survey
11. Randomised trial of prophylactic daily aspirin in British male doctors
12. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice?
13. Underuse of aspirin in a referral population with documented coronary heart disease